news
Injectable self-assembled nanomaterials developed for sustained drug delivery
New injectable delivery system can slowly release drug carriers for months...
List view / Grid view
Vaccines
news
Robotic method isolates high-producing cell lines for HIV vaccine production
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested...
news
Cancer vaccine eliminates tumours
Injecting minute amounts of two immune-stimulating agents directly into solid tumours in mice can eliminate all traces of cancer...
news
Zika vaccine candidate receives FDA fast track designation
The FDA has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate...
news
Pyridostigmine reverses paediatric complications of botulinum toxin therapy
Physicians have reported the first paediatric use of pyridostigmine to reverse complications from botulinum toxin therapy...
news
Nanoparticle vaccine offers universal protection against influenza
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity...
news
BM32 vaccine developed against rhinitis
Researchers have shown that the synthetically manufactured vaccine BM32 relieves the symptoms of rhinitis...
news
Heroin vaccine could tackle opioid addiction
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
news
Single-dose vaccine could provide faster protection against cholera
Researchers have shown that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks of cholera...
news
FDA approves first once-monthly buprenorphine injection for OUD
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for moderate-to-severe opioid use disorder...
news
Gene-based Zika vaccine is safe and immunogenic in healthy adults
Results from two Phase 1 clinical trials show an experimental Zika vaccine is safe and induces an immune response in healthy adults.
news
Neoantigen-based immunotherapy targets misshapen protein in DIPG
Children with an extremely deadly form of brain cancer may benefit from a new treatment that aims to direct an immune response against an abnormally shaped protein found on cancer cells...
product
FUJIFILM Diosynth Biotechnologies testing services
Technical leadership in contract development and manufacturing...
news
Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory diseases...
news
EMA grants marketing authorisation for subcutaneous formulation of Benlysta against lupus
The EU has approved a new subcutaneous formulation of Benlysta, as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus...
